Literature DB >> 8031046

Transplacental pharmacokinetics of dideoxyinosine in pigtailed macaques.

C M Pereira1, C Nosbisch, H R Winter, W L Baughman, J D Unadkat.   

Abstract

To determine whether dideoxyinosine is actively transported across the placenta, four pregnant macques (Macaca nemestrina) near term and their fetuses were infused intravenously in random order with simultaneous doses of dideoxyinosine (42.5 micrograms/min/kg of body weight) and antipyrine (41.7 micrograms/min/kg) for 30 h. The infusions took place after the dams had been chronically catheterized at 128 +/- 0.8 days of gestation. In a third infusion, the dams alone received a higher dosage of dideoxyinosine (425 micrograms/min/kg) and the same dosage of antipyrine (41.7 micrograms/min/kg). Samples of maternal and fetal blood and amniotic fluid were collected at intervals for up to 30 h. The concentrations of dideoxyinosine and antipyrine were determined by high-performance liquid chromatography. The transplacental maternal-fetal drug clearances were compared by the paired Student's t test. The ratio (mean +/- standard deviation) of the steady-state plasma dideoxyinosine concentration in the fetus to that in the dam was 0.49 +/- 0.10 at the low dideoxyinosine infusion rate and 0.51 +/- 0.00 at the high dideoxyinosine infusion rate. The clearance associated with maternal-fetal transfer of the drug, CLdf (0.38 +/- 0.21 ml/min/kg), was not significantly different (P > 0.05) from the clearance associated with fetal-maternal transfer of the drug, CLfd (0.56 +/- 0.27 ml/min/kg). Also, CLdf was not significantly different (P > 0.05) from CLfd when normalized with respect to the corresponding transplacental clearance of antipyrine (0.07 +/- 0.04 CLdf versus 0.09 +/- 0.04 CLfd). ur data indicate that passage of dideoxyinosine across the placenta in pregnant M. nemestrina near term is passive and constant over the dosage range studied.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8031046      PMCID: PMC284542          DOI: 10.1128/AAC.38.4.781

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  3'-azido-3'-deoxythymidine and acyclovir: antiviral nucleoside analogues with unusual cell membrane permeation properties.

Authors:  T P Zimmerman; K L Prus; W B Mahony; B A Domin
Journal:  Adv Exp Med Biol       Date:  1989       Impact factor: 2.622

2.  Alternatives to chronic restraint of nonhuman primates.

Authors:  W R Morton; G H Knitter; P M Smith; T G Susor; K Schmitt
Journal:  J Am Vet Med Assoc       Date:  1987-11-15       Impact factor: 1.936

3.  The contribution of transplacental clearances and fetal clearance to drug disposition in the ovine maternal-fetal unit.

Authors:  H H Szeto; J G Umans; S I Rubinow
Journal:  Drug Metab Dispos       Date:  1982 Jul-Aug       Impact factor: 3.922

4.  Pharmacokinetics of zidovudine (azidothymidine). I. Transplacental transfer.

Authors:  A Lopez-Anaya; J D Unadkat; L A Schumann; A L Smith
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

5.  Initial studies on the cellular pharmacology of 2',3'-dideoxyinosine, an inhibitor of HIV infectivity.

Authors:  G Ahluwalia; D A Cooney; H Mitsuya; A Fridland; K P Flora; Z Hao; M Dalal; S Broder; D G Johns
Journal:  Biochem Pharmacol       Date:  1987-11-15       Impact factor: 5.858

6.  2',3'-Dideoxyinosine is not metabolized in human placenta.

Authors:  J T Dalton; J L Au
Journal:  Drug Metab Dispos       Date:  1993 May-Jun       Impact factor: 3.922

7.  Pharmacokinetics of clearance in the maternal-fetal amniotic fluid system of the rat.

Authors:  T Nanbo
Journal:  Toxicol Appl Pharmacol       Date:  1988-03-15       Impact factor: 4.219

8.  Maternal transmission of retroviral disease: transgenic mice as a rapid test system for evaluating perinatal and transplacental antiretroviral therapy.

Authors:  A H Sharpe; J J Hunter; R M Ruprecht; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

9.  3'-azido-3'-deoxythymidine. An unusual nucleoside analogue that permeates the membrane of human erythrocytes and lymphocytes by nonfacilitated diffusion.

Authors:  T P Zimmerman; W B Mahony; K L Prus
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

10.  The application of bovine brain microvessel endothelial-cell monolayers grown onto polycarbonate membranes in vitro to estimate the potential permeability of solutes through the blood-brain barrier.

Authors:  M V Shah; K L Audus; R T Borchardt
Journal:  Pharm Res       Date:  1989-07       Impact factor: 4.200

View more
  12 in total

1.  Implications of gender and pregnancy for antiretroviral drug dosing.

Authors:  Brookie M Best; Edmund V Capparelli
Journal:  Curr Opin HIV AIDS       Date:  2008-05       Impact factor: 4.283

2.  In vivo maternal-fetal pharmacokinetics of stavudine (2',3'-didehydro-3'-deoxythymidine) in pigtailed macaques (Macaca nemestrina).

Authors:  A Odinecs; C Nosbisch; R D Keller; W L Baughman; J D Unadkat
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

3.  Development of a Novel Maternal-Fetal Physiologically Based Pharmacokinetic Model I: Insights into Factors that Determine Fetal Drug Exposure through Simulations and Sensitivity Analyses.

Authors:  Zufei Zhang; Marjorie Z Imperial; Gabriela I Patilea-Vrana; Janak Wedagedera; Lu Gaohua; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2017-06-06       Impact factor: 3.922

4.  Prenatal and postpartum pharmacokinetics of stavudine (2',3'-didehydro-3'-deoxythymidine) and didanosine (dideoxyinosine) in pigtailed macaques (Macaca nemestrina).

Authors:  A Odinecs; C Pereira; C Nosbisch; J D Unadkat
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

Review 5.  Antiretroviral therapy in pregnancy: a focus on safety.

Authors:  G P Taylor; N Low-Beer
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

6.  Maternal-fetal transfer and amniotic fluid accumulation of nucleoside analogue reverse transcriptase inhibitors in human immunodeficiency virus-infected pregnant women.

Authors:  Hélène Chappuy; Jean-Marc Tréluyer; Vincent Jullien; Jérôme Dimet; Elisabeth Rey; Maria Fouché; Ghislaine Firtion; Gérard Pons; Laurent Mandelbrot
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

7.  Zidovudine does not affect transplacental transfer or systemic clearance of stavudine (2',3'-didehydro-3'-deoxythymidine) in the pigtailed macaque (Macaca nemestrina).

Authors:  A Odinecs; C Nosbisch; J D Unadkat
Journal:  Antimicrob Agents Chemother       Date:  1996-06       Impact factor: 5.191

8.  Pharmacokinetics of dideoxyinosine in neonatal pigtailed macaques.

Authors:  C M Pereira; C Nosbisch; J D Unadkat
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

9.  Effect of zidovudine on transplacental pharmacokinetics of ddI in the pigtailed macaque (Macaca nemestrina).

Authors:  C M Pereira; C Nosbisch; W L Baughman; J D Unadkat
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

Review 10.  Antiretroviral bioanalysis methods of tissues and body biofluids.

Authors:  Robin DiFrancesco; Getrude Maduke; Rutva Patel; Charlene R Taylor; Gene D Morse
Journal:  Bioanalysis       Date:  2013-02       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.